Selective Targeting of a Maladaptive Adipokine—But Not of a Traditional Hemodynamic Phenotype—Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction
Selective Targeting of a Maladaptive Adipokine—But Not of a Traditional Hemodynamic Phenotype—Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction. // JACC: Heart Failure. – URL: https://www.sciencedirect.com/science/article/pii/S2213177926004592?dgcid=rss_sd_all
Selective Targeting of a Maladaptive Adipokine—But Not of a Traditional Hemodynamic Phenotype—Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure. https://www.sciencedirect.com/science/article/pii/S2213177926004592?dgcid=rss_sd_all
“Selective Targeting of a Maladaptive Adipokine—But Not of a Traditional Hemodynamic Phenotype—Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction.” JACC: Heart Failure.
@article{article51196,
title = {Selective Targeting of a Maladaptive Adipokine—But Not of a Traditional Hemodynamic Phenotype—Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction},
journal = {JACC: Heart Failure},
url = {https://www.sciencedirect.com/science/article/pii/S2213177926004592?dgcid=rss_sd_all}
}